High Flow Nasal Cannula Compared to Standard Oxygen for Endoscopic Ultrasound
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06704867
- Status
- Enrolling By Invitation
Conditions
- Endoscopic Ultrasound
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- High flow nasal cannula — OTHERSubjects undergoing endoscopic ultrasound will receive high flow nasal cannula during the procedure
Study Details
The purpose of the study is to evaluate the use of high flow nasal cannula versus standard oxygen therapy for high-risk patients undergoing endoscopy procedures.
Key Dates
- Start date
- Jul 14, 2025
- Status verified
- Jan 2026
- Primary completion
- Sep 30, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- No Intervention: Standard oxygen therapyStandard oxygen therapy will be initiated utilizing 2-4 liters of oxygen with a nasal cannula.
- Experimental: High Flow Nasal CannulaA high flow oxygen device with 100% FiO2 will be initiated prior to endoscopic ultrasound.
Primary Outcome Measure
Decrease recovery time [ Time Frame: 4 hours ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55901 | - |
Find similar trials in Rochester, MN
By research site